Lipodom Analytics was established by highly ranked founders to serve R&D needs by multidisciplinary approach with high- tech analytical instruments.
Our mission is the development of diagnostic products to prevent and detect human diseases that presently lack proper and painless diagnosis, effective therapies or are viewed as untreatable. We wish to exploit the unique properties of these methods to develop effective tools for neurodegenerative (Alzheimer's, Parkinson's, ALS), cancer and metabolic diseases (diabetes and its complications, lipid storage diseases).
We have the ability of planning, designing, implementing and exploiting R&D projects by the knowledge of PMI standards in project management and a massive experience on mass spectrometry and general medicine, clinical research and marketing.
We provide state of the art lipidomics service for academic and industrial partners. We perform lipidomics by high-resolution shotgun mass spectrometry and can identify and quantify hundreds of phospholipid, sphingolipid and glycerolipid species from sub-milligram amount (wet weight) of human and animal samples.